Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Memorandum and Articles of Association of Moonlake Immunotherapeutics
- 10.2 Amended and Restated Shareholders' Agreement, Dated As of April 5, 2022, by and Among Moonlake Immunotherapeutics, Moonlake Immunotherapeutics Ag and the Investors Signatory Thereto
- 10.5 Amended and Restated Registration Rights Agreement, Dated As of April 5, 2022, by and Among the Moonlake Immunotherapeutics, Helix Holdings LLC and the Holders Signatory Thereto
- 10.7 Form of Subscription Agreement
- 10.8 Moonlake Immunotherapeutics 2022 Equity Incentive Plan
- 10.33 Form of Non-employee Director Stock Option Agreement
- 14.1 Code of Business Conduct and Ethics
- 21.1 Subsidiaries of Moonlake Immunotherapeutics
- 99.1 Press Release Issued by Moonlake Immunotherapeutics on April 5, 2022
- 99.2 Moonlake Immunotherapeutics Unaudited Pro Forma Condensed Combined Balance Sheet As of December 31, 2021 and the Unaudited Pro Forma Condensed Combined Statement of Operations for the Year Ended December 31, 2021
- Download Excel data file
- View Excel data file
MLTX similar filings
- 17 Jun 22 Changes in Registrant's Certifying Accountant
- 7 Jun 22 Regulation FD Disclosure
- 16 May 22 Completion of Acquisition or Disposition of Assets
- 11 Apr 22 Entry into a Material Definitive Agreement
- 31 Mar 22 Submission of Matters to a Vote of Security Holders
- 24 Mar 22 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
- 25 Feb 22 Entry into a Material Definitive Agreement
Filing view
External links